[go: up one dir, main page]

SI2120878T1 - Dozirna oblika, ki vsebuje dve aktivni farmacevtski sestavini v različnih fizičnih oblikah - Google Patents

Dozirna oblika, ki vsebuje dve aktivni farmacevtski sestavini v različnih fizičnih oblikah

Info

Publication number
SI2120878T1
SI2120878T1 SI200831315T SI200831315T SI2120878T1 SI 2120878 T1 SI2120878 T1 SI 2120878T1 SI 200831315 T SI200831315 T SI 200831315T SI 200831315 T SI200831315 T SI 200831315T SI 2120878 T1 SI2120878 T1 SI 2120878T1
Authority
SI
Slovenia
Prior art keywords
dosage form
different physical
active pharmaceutical
form containing
pharmaceutical ingredients
Prior art date
Application number
SI200831315T
Other languages
English (en)
Inventor
Sandra Blundell
Panagiotis Keramidas
Brett Antony Mooney
Todd James Rutherford
Original Assignee
Alphapharm Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007900682A external-priority patent/AU2007900682A0/en
Application filed by Alphapharm Pty Ltd filed Critical Alphapharm Pty Ltd
Publication of SI2120878T1 publication Critical patent/SI2120878T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200831315T 2007-02-09 2008-02-11 Dozirna oblika, ki vsebuje dve aktivni farmacevtski sestavini v različnih fizičnih oblikah SI2120878T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2007900682A AU2007900682A0 (en) 2007-02-09 Novel Formulation
PCT/AU2008/000169 WO2008095263A1 (en) 2007-02-09 2008-02-11 A dosage form containing two or more active pharmaceutical ingredients in different physical forms
EP20080706056 EP2120878B1 (en) 2007-02-09 2008-02-11 A dosage form containing two active pharmaceutical ingredients in different physical forms

Publications (1)

Publication Number Publication Date
SI2120878T1 true SI2120878T1 (sl) 2014-12-31

Family

ID=39681201

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831315T SI2120878T1 (sl) 2007-02-09 2008-02-11 Dozirna oblika, ki vsebuje dve aktivni farmacevtski sestavini v različnih fizičnih oblikah

Country Status (15)

Country Link
US (1) US9095519B2 (sl)
EP (1) EP2120878B1 (sl)
JP (1) JP5467870B2 (sl)
CN (1) CN101674811B (sl)
AU (1) AU2008213744B2 (sl)
CA (1) CA2677623C (sl)
CY (1) CY1115652T1 (sl)
DK (1) DK2120878T3 (sl)
ES (1) ES2522297T3 (sl)
HR (1) HRP20141008T1 (sl)
NZ (1) NZ599031A (sl)
PL (1) PL2120878T3 (sl)
PT (1) PT2120878E (sl)
SI (1) SI2120878T1 (sl)
WO (1) WO2008095263A1 (sl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100189797A1 (en) * 2002-06-10 2010-07-29 Julien Mendlewicz Oral antidepressant formulation
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
EP2184055A1 (en) * 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate
CN101780078B (zh) * 2010-02-10 2012-02-29 威特(湖南)药业有限公司 替米沙坦和氨氯地平复方制剂及其制备方法
EP2368543A1 (en) 2010-03-25 2011-09-28 KRKA, tovarna zdravil, d.d., Novo mesto Method of preparing a granulated pharmaceutical composition comprising simvastatin and/or ezetimibe
EA201691986A1 (ru) * 2010-05-06 2017-03-31 СиЭйЭл ИНТЕРНЕШНЛ ЛИМИТЕД Фармацевтическая композиция, содержащая аспирин и бисопролол
CN102247366B (zh) * 2010-05-18 2015-04-15 广州白云山制药股份有限公司广州白云山制药总厂 包括依那普利和非洛地平的药物组合物缓释制剂
CN102028670A (zh) * 2010-09-06 2011-04-27 邓俐丽 一种包含替米沙坦和钙离子通道拮抗剂的复方胶囊剂
KR20120068277A (ko) * 2010-12-17 2012-06-27 한미사이언스 주식회사 ＨＭＧ－ＣｏＡ 환원효소 억제제 및 아스피린을 포함하는 약제학적 복합제제
MX2014004679A (es) 2011-10-21 2014-08-01 Takeda Pharmaceutical Preparacion de liberacion sostenida.
PL2793866T5 (pl) 2011-12-21 2023-12-04 Elanco Tiergesundheit Ag Tabletka dwuwarstwowa zawierająca chlorowodorek benazeprylu i pimobendan
CN103169704A (zh) * 2011-12-26 2013-06-26 上海复星医药产业发展有限公司 烟酸和辛伐他汀复方缓释胶囊制剂及其制备方法
CA2864456A1 (en) 2012-02-17 2013-08-22 Egis Gyogyszergyar Zrt. Pharmaceutical formulation having improved stability
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
CN102670630B (zh) * 2012-05-23 2013-11-27 重庆康刻尔制药有限公司 一种缬沙坦与氢氯噻嗪药物组合物胶囊剂及其制备方法
CN104582692A (zh) * 2012-08-28 2015-04-29 中化帝斯曼制药有限公司荷兰公司 包含抗生素和β-内酰胺酶抑制剂的组合物，其中抗生素和β-内酰胺酶抑制剂中的至少一种是迷你片剂的形式
EP2810644A1 (en) * 2013-06-06 2014-12-10 Ferrer Internacional, S.A. Oral formulation for the treatment of cardiovascular diseases
HUP1300496A2 (hu) 2013-08-16 2015-03-02 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Stabil kombinációs gyógyszerkészítmény
CN103462903B (zh) * 2013-08-26 2016-06-22 中国人民解放军第150中心医院 一种盐酸吡格列酮缓释微丸制剂的制备工艺
WO2015038854A1 (en) * 2013-09-13 2015-03-19 R.P. Scherer Technologies, Llc Encased-pellet tablets
HU231036B1 (hu) * 2013-09-30 2019-12-30 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Koleszterin bioszintézis gátló hatóanyagot és koleszterin abszorpciót gátló hatóanyagot tartalmazó kombinációs gyógyszerkészítmény
US20150132410A1 (en) * 2013-11-14 2015-05-14 Michael M. Jacobs Compositions and methods for the prevention and treatment of alcohol-induced hangover syndrome
KR101910901B1 (ko) * 2013-11-29 2018-10-24 한미약품 주식회사 암로디핀, 로자탄 및 로수바스타틴을 포함하는 약제학적 복합 제제
CN104382896A (zh) * 2014-11-04 2015-03-04 万全万特制药江苏有限公司 含有依折麦布和辛伐他汀的药物组合物
CN107920987A (zh) * 2015-05-26 2018-04-17 艾萨·欧蒂迪 控制延缓释放普瑞巴林
EP3328494A4 (en) 2015-08-01 2019-04-03 Stephen J. Petti COMPOSITIONS AND METHODS FOR COMBINING PHARMACOLOGICAL TREATMENTS TO INDUCTION EXTENDED, Mild Acceptance of BODY CORE TEMPERATURE
FR3040303B1 (fr) * 2015-08-27 2019-04-05 Les Laboratoires Servier Suivi Par Sabine Goudeau-Wenger Composition pharmaceutique comprenant un inhibiteur de la hmg-coa reductase et un inhibiteur eca
JP6831645B2 (ja) * 2016-06-14 2021-02-17 エルメッド株式会社 ガランタミン含有医薬組成物、医薬組成物におけるガランタミンの安定化方法、及びガランタミンの安定化剤
UA125535C2 (uk) 2017-07-17 2022-04-13 Елі Ліллі Енд Компані Фармацевтичні композиції
KR102500643B1 (ko) * 2019-04-18 2023-02-16 한미약품 주식회사 에제티미브 및 로사르탄을 포함하는 약제학적 복합제제
CN111388480B (zh) * 2020-03-26 2022-05-31 江苏长泰药业有限公司 一种奥氮平盐酸氟西汀复方制剂及其制备方法
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
DE3627423A1 (de) * 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5948441A (en) * 1988-03-07 1999-09-07 The Liposome Company, Inc. Method for size separation of particles
JP3170069B2 (ja) * 1992-10-06 2001-05-28 日水製薬株式会社 徐放性顆粒剤
NZ248813A (en) * 1992-11-25 1995-06-27 Eastman Kodak Co Polymeric grinding media used in grinding pharmaceutical substances
MY115461A (en) 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
JP2000516222A (ja) 1996-08-15 2000-12-05 ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング 嚥下が容易な経口医薬組成物
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
GT199800127A (es) 1997-08-29 2000-02-01 Combinaciones terapeuticas.
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
US6960577B2 (en) * 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
EA004539B1 (ru) * 1998-05-22 2004-06-24 Эли Лилли Энд Компани Комбинационная терапия для лечения резистентной депрессии
EP1005863A1 (en) 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
HUP0104778A3 (en) 1998-12-24 2004-05-28 Janssen Pharmaceutica Nv Controlled release galantamine composition
AR030920A1 (es) 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
BRPI0206432A2 (pt) * 2001-01-12 2016-10-25 Sun Pharmaceutical Ind Ltd métodos para administrar dois ou mais agentes terapêuticos ativos e para tratar diabetes melito ou sintomas associados com diabetes melito em um humano e sistema de liberação espaçada de medicamento
DE50113344D1 (de) * 2001-01-31 2008-01-17 Evonik Roehm Gmbh Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen
US6669955B2 (en) * 2001-08-28 2003-12-30 Longwood Pharmaceutical Research, Inc. Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
WO2003077825A2 (en) * 2002-03-12 2003-09-25 Microdose Technologies, Inc. Site specific delivery of co-administered drugs via inhalation
US6690577B2 (en) * 2002-07-02 2004-02-10 Hewlett-Packard Development Company, L.P. Air guide
RU2333745C2 (ru) 2002-10-25 2008-09-20 Лабофарм Инк. Композиции с контролируемым высвобождением
JP4616009B2 (ja) 2002-12-26 2011-01-19 ポーゼン インコーポレイテッド ＮＳＡＩＤｓおよびトリプタンを含有する多層剤型
WO2004062552A2 (en) * 2003-01-09 2004-07-29 Galephar M/F Pharmaceutical composition containing a nsaid and a benzimidazole derivative
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
CA2534660A1 (en) * 2003-08-05 2005-02-10 Galephar M/F Single unit pharmaceutical composition comprising a mixture of a fibrate and an homocysteine reducing agent
UA87471C2 (uk) * 2003-09-03 2009-07-27 Фарматон С.А. Капсули, які містять пелети з діючими речовинами, які відрізняються між собою профілями вивільнення з них діючих речовин
EP1901718A4 (en) * 2005-06-13 2012-07-18 Elan Pharma Int Ltd TICLOPIDINE COMPOSITIONS WITH MODIFIED RELEASE

Also Published As

Publication number Publication date
PL2120878T3 (pl) 2015-01-30
CN101674811A (zh) 2010-03-17
AU2008213744B2 (en) 2013-12-05
JP2010518028A (ja) 2010-05-27
AU2008213744A1 (en) 2008-08-14
EP2120878A1 (en) 2009-11-25
EP2120878B1 (en) 2014-07-30
HRP20141008T1 (hr) 2015-01-02
CA2677623C (en) 2015-04-07
ES2522297T3 (es) 2014-11-14
DK2120878T3 (da) 2014-11-03
CA2677623A1 (en) 2008-08-14
US9095519B2 (en) 2015-08-04
CN101674811B (zh) 2015-08-19
US20100092549A1 (en) 2010-04-15
EP2120878A4 (en) 2013-05-08
NZ599031A (en) 2013-11-29
PT2120878E (pt) 2014-11-05
WO2008095263A1 (en) 2008-08-14
JP5467870B2 (ja) 2014-04-09
CY1115652T1 (el) 2017-01-25

Similar Documents

Publication Publication Date Title
PT2120878E (pt) Forma farmacêutica contendo duas ou mais substancias ativas em diferentes formas físicas
IL275890A (en) A pharmaceutical preparation containing rasgelin and pramipexole
PL2399579T3 (pl) Farmaceutyczne postacie dawkowania
IL251539A0 (en) Single pharmaceutical dosage form
ZA201006029B (en) Pharmaceutical dosage form
IL206159A0 (en) Oral pharmaceutical dosage forms
IL208774A0 (en) Compositions comprising weakly basic drugs and controlled-release dosage forms
IL185390A0 (en) A solid pharmaceutical dosage formulation
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
IL194007A0 (en) Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
SG10201406016SA (en) Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
ZA201005015B (en) Solid pharmaceutical dosage form
EP2112925A4 (en) SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
PL2167033T4 (pl) Podawana raz dziennie doustna postać dawkowania zawierająca takrolimus
ZA200903854B (en) A gastroretentive pharmaceutical dosage form
ZA201100615B (en) Appetising medicament for oral administration in solid form
IL197871A0 (en) Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers
ZA200903858B (en) Pharmaceutical dosage form
ZA200808420B (en) Pharmaceutical composition comprising anti-mirna anti-sense oligonucleotides
ZA200803152B (en) Oramucosal pharmaceutical dosage form
IL212409A0 (en) Pharmaceutical dispenser and use thereof
ZA200903855B (en) A pharmaceutical dosage form
GB0623405D0 (en) Manifold for use in medicament dispenser
ZA200902498B (en) Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers